New mutations and horizontal transfer of rpoB among rifampin-resistant Streptococcus pneumoniae from four Spanish hospitals

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 6, 2005, Pages 2237-2245

  Ferrándiz, María José ^a   Ardanuy, Carmen ^b   Liñares, Josefina ^b   García Arenzana, José María ^c   Cercenado, Emilia ^d   Fleites, Ana ^e   De La Campa, Adela G ^a   Pallarés, Román ^b   García, Ernesto ^f   Casal, Julio ^a   Fenoll, Asuncion ^a   Bouza, Emilio ^d   Baquero, Fernando ^g   Soriano, Francisco ^h   Prieto, José ^h   Garau, Javier ⁱ   Martínez Lacasa, Javier ⁱ   Latorre, Cristina ^j   Pérez Trallero, Emilio ^c   García De Lomas, Juan ^k  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL DONOSTIA   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^e HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^f CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^g HOSPITAL RAMÓN Y CAJAL   (Spain)

^h Clínico Hospital   (Spain)

ⁱ HOSPITAL MÚTUA DE TERRASSA   (Spain)

^j HOSPITAL SANT JOAN DE DÉU   (Spain)

^k HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; PENICILLIN G; RIFAMPICIN; TETRACYCLINE;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CONJUNCTIVITIS; GENE CLUSTER; GENE MUTATION; GENETIC RECOMBINATION; GENETIC TRANSFORMATION; GEOGRAPHIC DISTRIBUTION; HORIZONTAL GENE TRANSFER; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RPOB GENE; SEROTYPE; SPAIN; STREPTOCOCCUS PNEUMONIAE;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BASE SEQUENCE; DNA-DIRECTED RNA POLYMERASES; DRUG RESISTANCE, BACTERIAL; GENE TRANSFER, HORIZONTAL; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; PHYLOGENY; PNEUMOCOCCAL INFECTIONS; RIFAMPIN; SEQUENCE ANALYSIS, DNA; SPAIN; STREPTOCOCCUS PNEUMONIAE;

EID: 21144432359     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.6.2237-2245.2005     Document Type: Article

References (40)

1. Amsterdam, D. 1986. Susceptibility testing of antimicrobials in liquid media. In V. Lorian (ed.), Antibiotics in laboratory medicine. Lippincott Williams & Wilkins, Baltimore, Md.
2. Aubry-Damon, H., M. Galimand, G. Gerbaud, and P. Courvalin. 2002. rpoB mutation conferring rifampin resistance in Streptococcus pyogenes. Antimicrob. Agents Chemother. 46:1571-1573.
3. Aubry-Damon, H., C. J. Soussy, and P. Courvalin. 1998. Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 42:2590-2594.
4. Balsalobre, L., M. J. Ferrándiz, J. Liñares, F. Tubau, and A. G. de la Campa. 2003. Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniae. Antimicrob. Agents Chemother. 47:2072-2081.
5. Bradley, J. S., and W. M. Scheld. 1997. The challenge of penicillin-resistant Streptococcus pneumoniae meningitis: current antibiotic therapy in the 1990s. Clin. Infect. Dis. 24:213-221.
6. Campbell, E. A., N. Korzheva, A. Mustaev, K. Murakami, S. Nair, A. Goldfarb, and S. A. Darst. 2001. Structural mechanism for rifampicin inhibition of bacterial RNA polymerase. Cell 104:901-912.
7. Chen, J. Y., C. P. Fung, F. Y. Chang, L. Y. Huang, J. C. Chang, and L. K. Siu. 2004. Mutations of rpoB gene in rifampicin-resistant Streptococcus pneumoniae in Taiwan. J. Antimicrob. Chemother. 53:375-378.
8. Coffey, T., S. Berron, M. Daniels, M. García-Leoni, E. Cercenado, E. Bouza, A. Fenoll, and B. G. Spratt. 1996. Multiply antibiotic-resistant Streptococcus pneumoniae recovered from Spain hospitals (1988-1994): novel major clones of serotypes 14, 19F, and 15F. Microbiology 142:2747-2757.
9. Cruchaga, S., M. Pérez-Vázquez, F. Román, and J. Campos. 2003. Molecular basis of rifampicin resistance in Haemophilus influenzae. J. Antimicrob. Chemother. 56:1011-1014.
10. de la Campa, A. G., L. Balsalobre, C. Ardanuy, A. Fenoll, E. Pérez-Trallero, J. Liñares, and the Spanish Pneumococcal Infection Study Network G03/ 103. 2004. Fluoroquinolone resistance in penicillin-resistant Streptococcus pneumoniae clones, Spain. Emerg. Infect. Dis. 10:1751-1759.
11. Dicuonzo, G., G. Gerardi, R. E. Gertz, F. D'Ambrosio, A. Goglio, G. Lorino, S. Recchia, A. Pantosti, and B. Beall. 2002. Genotypes of invasive pneumococcal isolates recently recovered from Italian patients. J. Clin. Microbiol. 40:3660-3665.
12. Doern, G. V., K. P. Heilmann, H. K. Huynh, P. R. Rhomberg, S. L. Coffman, and A. B. Brueggemann. 2001. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrob. Agents Chemother. 45:1721-1729.
13. Dowson, C. G., A. Hutchinson, N. Woodford, A. P. Johnson, R. C. George, and B. G. Spratt. 1990. Penicillin-resistant viridans streptococci have obtained altered penicillin-binding protein genes from penicillin-resistant strains of Streptococcus pneumoniae. Proc. Natl. Acad. Sci. USA 87:5858-5862.
14. Enright, M., and B. G. Spratt. 1998. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144:3049-3060.
15. Enright, M., P. Zawadski, P. Pickerill, and C. G. Dowson. 1998. Molecular evolution of rifampicin resistance in Streptococcus pneumoniae. Microb. Drug Resist. 4:65-70.
16. Enright, M. C., A. Fenoll, D. Griffiths, and B. G. Spratt. 1999. The three major Spanish clones of penicillin-resistant Streptococcus pneumoniae are the most common clones recovered in recent cases of meningitis in Spain. J. Clin. Microbiol. 37:3210-3216.
17. Fenoll, A., I. Jado, D. Vicioso, A. Pérez, and J. Casal. 1998. Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: update (1990-1996). J. Clin. Microbiol. 36:3447-3454.
18. García-Arenzana, J. M., M. Montes, and E. Pérez-Trallero. 1994. Are rifampin-resistant Streptococcus pneumoniae strains a consequence of the increase in cases of tuberculosis? Clin. Infect. Dis. 19:360-361.
19. Herrera, L., S. Jiménez, A. Valverde, M. A. García-Aranda, and J. A. Sáez-Nieto. 2003. Molecular analysis of rifampicin-resistant Mycobacterium tuberculosis isolated in Spain (1996-2001). Description of new mutations in the rpoB gene and review of the literature. Int. J. Antimicrob. Agents 21:403-408.
20. Jacobs, M. R., D. Felmingham, P. C. Applelbaum, R. N. Grüneberg, and The Alexander Project Group. 2003. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J. Antimicrob. Chemother. 52:229-246.
21. Jin, D. J., and Y. N. Zhou. 1996. Mutational analysis of structure-function relationship of RNA polymerase in Escherichia coli. Methods Enzymol. 273: 300-319.
22. Lacks, S. A. 1966. Integration efficiency and genetic recombination in pneumococcal transformation. Genetics 53:207-235.
23. Liñares, J., R. Pallarés, T. Alonso, J. L. Pérez, J. Ayats, F. Gudiol, P. F. Viladrich, and R. Martín,. 1992. Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990). Clin. Infect. Dis. 15:99-105.
24. Liñares, J., F. Tubau, and M. A. Dominguez. 1999. Antibiotic resistance in Streptococcus pneumoniae in Spain: an overview in the 1990s. In A. Tomasz (ed.), Streptococcus pneumoniae. Molecular biology and mechanisms of disease-update for the 1990s. Mary Ann Liebert Inc., New York, N.Y.
25. Marchese, A., S. Mannelli, E. Tonoli, F. Gorlero, M. Toni, and G. C. Schito. 2001. Prevalence of antimicrobial resistance in Streptococcus pneumoniae circulating in Italy: results of the Italian Epidemiological Observatory Survey. Microb. Drug Resist. 7:277-287.
26. Martínez-Lacasa, J., C. Cabellos, A. Martos, A. Fernández, F. Tubau, P. F. Viladrich, J. Liñares, and F. Gudiol. 2002. Experimental study of the efficacy of vancomycine, rifampicin and dexamethasone in the therapy of pneumococcal meningitis. J. Antimicrob. Chemother. 49:507-513.
27. Martín-Galiano, A. J., and A. G. de la Campa. 2003. High-efficiency generation of antibiotic-resistant strains of Streptococcus pneumoniae by PCR and transformation. Antimicrob. Agents Chemother. 47:1257-1261.
28. McGee, L., L. McDougal, J. Zhou, B. G. Spratt, F. C. Tenover, R. George, R. Hakenbeck, W. Hryniewicz, J. C. Lefevre, A. Tomasz, and K. P. Klugman. 2001. Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network. J. Clin. Microbiol. 39:2565-2571.
29. Meier, P. S., S. Utz, S. Aebi, and K. Mühlemann. 2003. Low-level resistance to rifampin in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 47:863-868.
30. National Committee for Clinical Laboratory Standards. 2004. Performance standards for antimicrobial susceptibility testing. Fourteenth informational supplement. NCCLS document M100-S14. National Committee for Clinical Laboratory Standards, Wayne, Pa.
31. Nielsen, K., P. Hindersson, N. Hoiby, and J. M. Bangsborg. 2000. Sequencing of the rpoB gene in Legionella pneumophila and characterization of mutations associated with rifampin resistance in the legionellaceae. Antimicrob. Agents Chemother. 44:2679-2683.
32. Padayachee, T., and K. P. Klugman. 1999. Molecular basis of rifampin resistance in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 43: 2361-2365.
33. Paris, M. M., S. M. Hickey, M. I. Uscher, S. Shelton, K. D. Olsen, and G. H. McCracken, 1994. Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob. Agents Chemother. 38:1320-1324.
34. 14-5 international multiresistant clone resistant to fluoroquinolones and other families of antibiotics. J. Antimicrob. Chemother. 51:715-719.
35. Reynolds, M. G. 2000. Compensatory evolution in rifampin-resistant Escherichia coli Genetics 156:1471-1481.
36. Subramanian, D., J. A. T. Sandoe, V. Keer, and M. H. Wilcox. 2003. Rapid spread of penicillin-resistant Streptococcus pneumoniae among high-risk hospital inpatients and the role of molecular typing in outbreak confirmation. J. Hosp. Infect. 54:99-103.
37. Tenover, F. C., R. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
38. van Tilburg, P. M. B., D. Bogaert, M. Sluijter, A. R. Jansz, R. de Groot, and P. W. M. Hermans. 2001. Emergence of rifampin-resistant Streptococcus pneumoniae as a result of antimicrobial therapy for penicillin-resistant strains. Clin. Infect. Dis. 33:e93-e96.
39. Wichelhaus, T. A., B. Böddinghaus, S. Besier, V. Schäfer, V. Brade, and A. Ludwig. 2002. Biological cost of rifampin from the perspective of Staphylococcus aureus. Antimicrob. Agents Chemother. 46:3381-3385.
40. Zhang, G., E. A. Campbell, L. Minakhin, C. Ritcher, K. Severinov, and S. A. Darst. 1999. Crystal structure of Thermus aquaticus core RNA polymerase at 3.3 A resolution. Cell 98:811-824.